UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Occult HBV infection

Seminars in immunopathology, 2013-01, Vol.35 (1), p.39-52

2013

Volltextzugriff (PDF)

Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis

Annals of hematology, 2011-10, Vol.90 (10), p.1219-1223

2011

Volltextzugriff (PDF)

Dynamic profile of the HBeAg-anti-HBe system in acute and chronic hepatitis B virus infection: A clinical-laboratory approach

Molecular biology reports, 2021, Vol.48 (1), p.843-854

de Almeida Pondé, Robério Amorim

2021

Volltextzugriff (PDF)

Reverse Vaccinology and Immunoinformatic Approach for Designing a Bivalent Vaccine Candidate Against Hepatitis A and Hepatitis B Viruses

Molecular biotechnology, 2024-09, Vol.66 (9), p.2362-2380

2024

Volltextzugriff (PDF)

Peculiarities in the designations of hepatitis B virus genes, their products, and their antigenic specificities: a potential source of misunderstandings

Virus genes, 2020-04, Vol.56 (2), p.109-119

2020

Volltextzugriff (PDF)

Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy

Hepatology international, 2022-04, Vol.16 (2), p.211-253

2022

Volltextzugriff (PDF)

Detection of HBV genome in the plasma and peripheral blood mononuclear cells of Iranian HBsAg negative patients with HIV infection: occult HBV infection

Archives of virology, 2018-06, Vol.163 (6), p.1559-1566

2018

Volltextzugriff (PDF)

Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S Vaccine

Medical microbiology and immunology, 2015-02, Vol.204 (1), p.57-68

2015

Volltextzugriff (PDF)

A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma

Investigational new drugs, 2019-04, Vol.37 (2), p.297-306

2019

Volltextzugriff (PDF)

Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog

Journal of gastroenterology, 2013-01, Vol.48 (1), p.13-21

2013

Volltextzugriff (PDF)

Evaluation of occult hepatitis B infection in tissue donors: a multicenter analysis in Spain

Cell and tissue banking, 2019-12, Vol.20 (4), p.513-526

2019

Volltextzugriff (PDF)

Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin

Virchows Archiv : an international journal of pathology, 2022-02, Vol.480 (2), p.403-413

2022

Volltextzugriff (PDF)

B-Cell Reconstitution and BAFF After Alemtuzumab (Campath-1H) Treatment of Multiple Sclerosis

Journal of clinical immunology, 2010-01, Vol.30 (1), p.99-105

2010

Volltextzugriff (PDF)

Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma

Digestive diseases and sciences, 2017-03, Vol.62 (3), p.784-793

2017

Volltextzugriff (PDF)

Anti-HBc IgG Levels: A Predictor of HBsAg Seroclearance in Chronic Hepatitis B Patients with Nucleos(t)ide Analogue-Induced HBeAg Seroclearance

Digestive diseases and sciences, 2022-01, Vol.67 (1), p.321-328

2022

Volltextzugriff (PDF)

Use of HBsAg quantification in the natural history and treatment of chronic hepatitis B

Hepatology international, 2020-01, Vol.14 (1), p.35-46

2020

Volltextzugriff (PDF)

Long-term outcome of entecavir treatment of nucleos(t)ide analogue-naïve chronic hepatitis B patients in Japan

Journal of gastroenterology, 2019-02, Vol.54 (2), p.182-193

2019

Volltextzugriff (PDF)

Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection

Digestive diseases and sciences, 2015-05, Vol.60 (5), p.1457-1464

2015

Volltextzugriff (PDF)

Droplet digital PCR detects high rate of TP53 R249S mutants in cell-free DNA of middle African patients with hepatocellular carcinoma

Clinical and experimental medicine, 2018-08, Vol.18 (3), p.421-431

2018

Volltextzugriff (PDF)

Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients

Journal of gastroenterology, 2016-08, Vol.51 (8), p.830-839

2016

Volltextzugriff (PDF)

Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy

Journal of gastroenterology, 2011-01, Vol.46 (1), p.9-16

2011

Volltextzugriff (PDF)

Dihydromyricetin inhibits Hepatitis B virus replication by activating NF-κB, MAPKs, and autophagy in HepG2.2.15 cells

Molecular biology reports, 2023-02, Vol.50 (2), p.1403-1414

2023

Volltextzugriff (PDF)

Severe hepatitis B virus reactivation related to ibrutinib monotherapy

Annals of hematology, 2017-04, Vol.96 (4), p.689-690

2017

Volltextzugriff (PDF)

Epigenetic Control of B Cell Development and B-Cell-Related Immune Disorders

Clinical Reviews in Allergy & Immunology, 2016-06, Vol.50 (3), p.301-311

2016

Volltextzugriff (PDF)

Hepatitis B virus infection assessed 3 to 18 years after vaccination in Cuban children and adolescents born to HBsAg-positive mothers

Archives of virology, 2017-08, Vol.162 (8), p.2393-2396

2017

Volltextzugriff (PDF)

1 – 25 von 51.236

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49.640)
Mit Volltextzugriff
(49.870)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(42.357)
Life Sciences & Biomedicine
(37.766)
Humans
(24.461)
Biomedical And Life Sciences
(13.468)
Male
(12.368)
Animals
(12.209)
Medicine
(12.164)
Medicine & Public Health
(11.721)
Female
(11.200)
Biomedicine
(8.431)
Biological And Medical Sciences
(7.874)
Oncology
(7.427)
Original Article
(7.024)
Cell Biology
(6.636)
Middle Aged
(6.552)
Life Sciences
(6.444)
Adult
(6.360)
Biochemistry
(5.357)
Biochemistry & Molecular Biology
(5.225)
Immunology
(5.191)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Springer journals
(51.128)
MEDLINE
(34.390)
Ovid
(26.674)
Ingenta
(25.241)
EZB Electronic Journals Library
(4.021)
Publisher website
(2.284)
JSTOR
(1.919)
IngentaConnect Journals
(1.449)
Wiley Journals
(616)
Psychology & Behavioral Sciences Collection (EBSCO)
(332)
De Gruyter journals
(321)
Springer Book Series (Lecture Notes)
(289)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(284)
Sociological Abstracts
(241)
Business Source Ultimate
(201)
Nexis Uni (LexisNexis)
(168)
Brill Online Journals
(150)
Applied Social Sciences Index & Abstracts (ASSIA)
(149)
Taylor & Francis Journals
(69)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Hematology
(979)
Digestive Diseases And Sciences
(882)
Inflammation
(866)
Molecular And Cellular Biochemistry
(856)
International Journal Of Hematology
(728)
Journal Of Clinical Immunology
(719)
Molecular Biology Reports
(690)
Archives Of Virology
(612)
Immunogenetics
(572)
Cancer Immunology Immunotherapy
(541)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Occult HBV infection

Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis

Dynamic profile of the HBeAg-anti-HBe system in acute and chronic hepatitis B virus infection: A clinical-laboratory approach

Reverse Vaccinology and Immunoinformatic Approach for Designing a Bivalent Vaccine Candidate Against Hepatitis A and Hepatitis B Viruses

Peculiarities in the designations of hepatitis B virus genes, their products, and their antigenic specificities: a potential source of misunderstandings

Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy

Detection of HBV genome in the plasma and peripheral blood mononuclear cells of Iranian HBsAg negative patients with HIV infection: occult HBV infection

Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S Vaccine

A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma

Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog

Evaluation of occult hepatitis B infection in tissue donors: a multicenter analysis in Spain

Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin

B-Cell Reconstitution and BAFF After Alemtuzumab (Campath-1H) Treatment of Multiple Sclerosis

Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma

Anti-HBc IgG Levels: A Predictor of HBsAg Seroclearance in Chronic Hepatitis B Patients with Nucleos(t)ide Analogue-Induced HBeAg Seroclearance

Use of HBsAg quantification in the natural history and treatment of chronic hepatitis B

Long-term outcome of entecavir treatment of nucleos(t)ide analogue-naïve chronic hepatitis B patients in Japan

Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection

Droplet digital PCR detects high rate of TP53 R249S mutants in cell-free DNA of middle African patients with hepatocellular carcinoma

Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients

Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy

Dihydromyricetin inhibits Hepatitis B virus replication by activating NF-κB, MAPKs, and autophagy in HepG2.2.15 cells

Severe hepatitis B virus reactivation related to ibrutinib monotherapy

Epigenetic Control of B Cell Development and B-Cell-Related Immune Disorders

Hepatitis B virus infection assessed 3 to 18 years after vaccination in Cuban children and adolescents born to HBsAg-positive mothers

Aktive Filter

Suchergebnisse filtern